These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 38371714)

  • 1. Giving Consent to the Ineffable.
    Villiger D
    Neuroethics; 2024; 17(1):11. PubMed ID: 38371714
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Are Psychedelic Experiences Transformative? Can We Consent to Them?
    Kious BM; Peterson A; McGuire AL
    Perspect Biol Med; 2024; 67(1):143-154. PubMed ID: 38662069
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transformative experience and informed consent to psychedelic-assisted psychotherapy.
    Jacobs E
    Front Psychol; 2023; 14():1108333. PubMed ID: 37303902
    [TBL] [Abstract][Full Text] [Related]  

  • 4. With great power comes great vulnerability: an ethical analysis of psychedelics' therapeutic mechanisms proposed by the REBUS hypothesis.
    Villiger D; Trachsel M
    J Med Ethics; 2023 Nov; 49(12):826-832. PubMed ID: 37045591
    [TBL] [Abstract][Full Text] [Related]  

  • 5. United States National Institutes of Health grant funding for psychedelic-assisted therapy clinical trials from 2006-2020.
    Barnett BS; Parker SE; Weleff J
    Int J Drug Policy; 2022 Jan; 99():103473. PubMed ID: 34624734
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ethical and Practical Considerations for the Use of Psychedelics in Psychiatry.
    Barber GS; Dike CC
    Psychiatr Serv; 2023 Aug; 74(8):838-846. PubMed ID: 36987705
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Essentials of Informed Consent to Psychedelic Medicine.
    Marks M; Brendel RW; Shachar C; Cohen IG
    JAMA Psychiatry; 2024 Jun; 81(6):611-617. PubMed ID: 38598209
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ethics and ego dissolution: the case of psilocybin.
    Smith WR; Sisti D
    J Med Ethics; 2020 May; ():. PubMed ID: 32461241
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Readiness of Psychiatrists to Implement Psychedelic-Assisted Psychotherapy.
    Page LA; Rehman A; Syed H; Forcer K; Campbell G
    Front Psychiatry; 2021; 12():743599. PubMed ID: 35756728
    [No Abstract]   [Full Text] [Related]  

  • 10. Prescribing meaning: hedonistic perspectives on the therapeutic use of psychedelic-assisted meaning enhancement.
    Miceli McMillan R
    J Med Ethics; 2021 Oct; 47(10):701-705. PubMed ID: 33148774
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Psychedelic Renaissance and Its Forensic Implications.
    Holoyda B
    J Am Acad Psychiatry Law; 2020 Mar; 48(1):87-97. PubMed ID: 31948993
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Psychedelic Knowledge and Opinions in Psychiatrists at Two Professional Conferences: An Exploratory Survey.
    Barnett BS; Beaussant Y; King F; Doblin R
    J Psychoactive Drugs; 2022; 54(3):269-277. PubMed ID: 34409921
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Compassionate use of psychedelics.
    Greif A; Šurkala M
    Med Health Care Philos; 2020 Sep; 23(3):485-496. PubMed ID: 32468195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ethical considerations for psychedelic-assisted therapy in military clinical settings.
    Hoener S; Wolfgang A; Nissan D; Howe E
    J Med Ethics; 2024 Mar; 50(4):258-262. PubMed ID: 37253556
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Psychedelic Psychiatry and the Consult-Liaison Psychiatrist: A Primer.
    Barnett BS; Greer GR
    J Acad Consult Liaison Psychiatry; 2021; 62(4):460-471. PubMed ID: 34210406
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ethical and legal issues in psychedelic harm reduction and integration therapy.
    Pilecki B; Luoma JB; Bathje GJ; Rhea J; Narloch VF
    Harm Reduct J; 2021 Apr; 18(1):40. PubMed ID: 33827588
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Should we be leery of being Leary? Concerns about psychedelic use by psychedelic researchers.
    Kious B; Schwartz Z; Lewis B
    J Psychopharmacol; 2023 Jan; 37(1):45-48. PubMed ID: 36377548
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ARC: a framework for access, reciprocity and conduct in psychedelic therapies.
    Spriggs MJ; Murphy-Beiner A; Murphy R; Bornemann J; Thurgur H; Schlag AK
    Front Psychol; 2023; 14():1119115. PubMed ID: 37251069
    [TBL] [Abstract][Full Text] [Related]  

  • 19. On the Relationship between Classic Psychedelics and Suicidality: A Systematic Review.
    Zeifman RJ; Singhal N; Breslow L; Weissman CR
    ACS Pharmacol Transl Sci; 2021 Apr; 4(2):436-451. PubMed ID: 33860173
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.